Knockdown of LIMp27 not only inhibited p53‐mutant CRC cell proliferation and tumorigenicity, but also cooperated with genotoxic drugs to inhibit p53‐mutant CRC xenograft growth. The gene discussed is TP53; the disease is colorectal carcinoma.